Court of Chancery of Delaware October 30, 2019, 2019-0159-MTZ (Fortis Advisors LLC v. Allergan W.C. Holding Inc.)
Also known as
United States · · · 30-10-2019
IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE
FORTIS ADVISORS LLC, in its )
capacity as the Shareholders’ )
Representative for the former )
stockholders of Oculeve, Inc., )
)
Plaintiff, )
)
v. ) C.A. No. 2019-0159-MTZ
)
ALLERGAN W.C. HOLDING INC., )
)
Defendant. )
MEMORANDUM OPINION
Date Submitted: July 9, 2019
Date Decided: October 30, 2019
Bradley R. Aronstam, Roger S. Stronach, ROSS ARONSTAM & MORITZ LLP,
Wilmington, Delaware; Martin S. Schenker, Matthew D. Caplan, Kristine A.
Forderer, COOLEY LLP, San Francisco, California; Attorneys for Plaintiff Fortis
Advisors LLC
Michael A. Barlow, Daniel J. McBride, ABRAMS & BAYLISS LLP, Wilmington,
Delaware; David W. Haller, COVINGTON & BURLING LLP, New York, New
York; Attorneys for Defendant Allergan W.C. Holding Inc.
ZURN, Vice Chancellor.
The parties to a merger dispute the seller’s entitlement to post-closing
milestone payment consideration. For the seller to earn the milestone payment, the
new company had to achieve a specifically defined enhanced treatment authorization
from the Federal Drug Administration. After the Federal Drug Administration gave
its authorization, the company declined to pay the seller the milestone payment.
The seller stockholders’ representative asserts the buyer breached the merger
agreement by refusing to pay the milestone payment and by failing to exercise
commercially reasonable efforts in pursuit of the authorization. The buyer moved
to dismiss, contending the enhanced treatment authorization did not trigger the
milestone payment, and that the buyer failed to allege sufficient facts in support of
its commercially reasonable efforts claim. This decision concludes that the seller
adequately alleged a breach of contract claim based on the plain meaning of the
contract and the authorization, and that the seller alleged sufficient facts to support
its commercially reasonable efforts claim. Accordingly, I deny the buyer’s motion
to dismiss.
I.
Read the full text
This document is published by courtlistener.com.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit